Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinxing Feng

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
The American Journal of Cardiology|December 12, 2018
Implications of Hyperuricemia in Severe Coronary Artery DiseaseCe Zhang, Lin Jiang, Lianjun Xu, et al.
Journal of Atherosclerosis and Thrombosis|March 5, 2019
Prognostic Value of Plasma Big Endothelin-1 Level among Patients with Three-Vessel Disease: A Cohort StudyCe Zhang, Jian Tian, Lin Jiang, et al.
The Lancet. Diabetes & Endocrinology|May 1, 2019
Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome StudyQiuhong Gong, Ping Zhang, Jinping Wang, et al.
Frontiers in Cardiovascular Medicine|June 20, 2022
Interaction Between Treatment and Age or Sex in Non-ST-Segment Elevation Acute Coronary Disease and Three-Vessel DiseaseTianyu Li, Lin Jiang, Lianjun Xu, et al.
Cardiovascular Diabetology|December 7, 2023
An elevated triglyceride-glucose index predicts adverse outcomes and interacts with the treatment strategy in patients with three-vessel diseaseYu Zhang, Ce Zhang, Lin Jiang, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 28, 2020
Comparison of Percutaneous Coronary Intervention, Coronary Artery Bypass Grafting and Medical Therapy in Non-ST Elevation Acute Coronary Syndrome Patients With 3-Vessel DiseaseSida Jia, Ce Zhang, Lin Jiang, et al.
BMC Cardiovascular Disorders|June 24, 2023
HMGCR gene polymorphism is associated with residual cholesterol risk in premature triple-vessel disease patients treated with moderate-intensity statinsJiawen Li, Xiaofang Tang, Jingjing Xu, et al.
The American Journal of Cardiology|December 23, 2019
Impact of Lipoprotein(a) on Long-Term (Mean 6.2 Years) Outcomes in Patients With Three-Vessel Coronary Artery DiseaseNa Xu, Lin Jiang, Lianjun Xu, et al.
Angiology|June 10, 2021
Relationship Between High-Sensitivity C-Reactive Protein and Long-Term Outcomes in Elderly Patients With 3-Vessel DiseaseYue Liu, Ce Zhang, Lin Jiang, et al.
Atherosclerosis|January 27, 2023
Machine learning improves mortality prediction in three-vessel diseaseXinxing Feng, Ce Zhang, Xin Huang, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The American Journal of Cardiology|December 12, 2018
Implications of Hyperuricemia in Severe Coronary Artery DiseaseCe Zhang, Lin Jiang, Lianjun Xu, et al.
Journal of Atherosclerosis and Thrombosis|March 5, 2019
Prognostic Value of Plasma Big Endothelin-1 Level among Patients with Three-Vessel Disease: A Cohort StudyCe Zhang, Jian Tian, Lin Jiang, et al.
The Lancet. Diabetes & Endocrinology|May 1, 2019
Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome StudyQiuhong Gong, Ping Zhang, Jinping Wang, et al.
Frontiers in Cardiovascular Medicine|June 20, 2022
Interaction Between Treatment and Age or Sex in Non-ST-Segment Elevation Acute Coronary Disease and Three-Vessel DiseaseTianyu Li, Lin Jiang, Lianjun Xu, et al.
Cardiovascular Diabetology|December 7, 2023
An elevated triglyceride-glucose index predicts adverse outcomes and interacts with the treatment strategy in patients with three-vessel diseaseYu Zhang, Ce Zhang, Lin Jiang, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 28, 2020
Comparison of Percutaneous Coronary Intervention, Coronary Artery Bypass Grafting and Medical Therapy in Non-ST Elevation Acute Coronary Syndrome Patients With 3-Vessel DiseaseSida Jia, Ce Zhang, Lin Jiang, et al.
BMC Cardiovascular Disorders|June 24, 2023
HMGCR gene polymorphism is associated with residual cholesterol risk in premature triple-vessel disease patients treated with moderate-intensity statinsJiawen Li, Xiaofang Tang, Jingjing Xu, et al.
The American Journal of Cardiology|December 23, 2019
Impact of Lipoprotein(a) on Long-Term (Mean 6.2 Years) Outcomes in Patients With Three-Vessel Coronary Artery DiseaseNa Xu, Lin Jiang, Lianjun Xu, et al.
Angiology|June 10, 2021
Relationship Between High-Sensitivity C-Reactive Protein and Long-Term Outcomes in Elderly Patients With 3-Vessel DiseaseYue Liu, Ce Zhang, Lin Jiang, et al.
Atherosclerosis|January 27, 2023
Machine learning improves mortality prediction in three-vessel diseaseXinxing Feng, Ce Zhang, Xin Huang, et al.
Pageof 5